The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in Hypertension: What Is the Clinical Significance?
Abstract
Metabolism of oxygen by cells generates potentially deleterious reactive oxygen species (ROS). Under normal conditions the rate and magnitude of oxidant formation is balanced by the rate of oxidant elimination. However, an imbalance between prooxidants and antioxidants results in oxidative stress, which is the pathogenic outcome of oxidant overproduction that overwhelms the cellular antioxidant capacity. The kidney and vasculature are rich sources of NADPH oxidase–derived ROS, which under pathological conditions play an important role in renal dysfunction and vascular damage. Strong experimental evidence indicates that increased oxidative stress and associated oxidative damage are mediators of renovascular injury in cardiovascular pathologies. Increased production of superoxide anion and hydrogen peroxide, reduced nitric oxide synthesis, and decreased bioavailability of antioxidants have been demonstrated in experimental and human hypertension. These findings have evoked considerable interest because of the possibilities that therapies targeted against free radicals by decreasing ROS generation or by increasing nitric oxide availability and antioxidants may be useful in minimizing vascular injury and renal dysfunction and thereby prevent or regress hypertensive end-organ damage. This article highlights current developments in the field of ROS and hypertension, focusing specifically on the role of oxidative stress in hypertension-associated vascular damage. In addition, recent clinical trials investigating cardiovascular benefits of antioxidants are discussed, and some explanations for the rather disappointing results from these studies are addressed. Finally, important avenues for future research in the field of ROS, oxidative stress, and redox signaling in hypertension are considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,655
Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Taniyama, Y., & Griendling, K. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000100443.09293.4f · Cited by 1,066
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassègue, B., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,032
Calcium and oxidative stress: from cell signaling to cell death
Ermak, G., & Davies, K. J. A. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(01)00108-0 · Cited by 871
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Cai, H., Griendling, K. K., & Harrison, D. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00233-5 · Cited by 687
Role of p47 phox in Vascular Oxidative Stress and Hypertension Caused by Angiotensin II
Landmesser, U., Cai, H., Dikalov, S., McCann, L., Hwang, J., Jo, H., Holland, S. M., & Harrison, D. G. (2002) · Hypertension · doi:10.1161/01.hyp.0000032100.23772.98 · Cited by 577
Endothelial Function and Oxidative Stress in Renovascular Hypertension
Higashi, Y., Sasaki, S., Nakagawa, K., Matsuura, H., Oshima, T., & Chayama, K. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013591 · Cited by 544
John, J., Ziebland, S., Yudkin, P., Roe, L., & Neil, H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)98858-6 · Cited by 527
Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension
Redón, J., Oliva, M. R., Tormos, C., Giner, V., Chaves, J., Iradi, A., & Sáez, G. T. (2003) · Hypertension · doi:10.1161/01.hyp.0000068370.21009.38 · Cited by 420
Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress
Virdis, A., Neves, M. F., Amiri, F., Viel, E., Touyz, R. M., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/01.hyp.0000034738.79310.06 · Cited by 399
Self-citationChabrashvili, T., Tojo, A., Onozato, M. L., Kitiyakara, C., Quinn, M. T., Fujita, T., Welch, W. J., & Wilcox, C. S. (2002) · Hypertension · doi:10.1161/hy0202.103264 · Cited by 377
Different Effect of Antihypertensive Drugs on Conduit Artery Endothelial Function
Ghiadoni, L., Magagna, A., Versari, D., Kardasz, I., Huang, Y., Taddei, S., & Salvetti, A. (2003) · Hypertension · doi:10.1161/01.hyp.0000070956.57418.22 · Cited by 368
Reactive oxygen species: Roles in blood pressure and kidney function
Wilcox, C. S. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0041-2 · Cited by 341
Chiarugi, P., & Cirri, P. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00174-9 · Cited by 331
Nishiyama, A., Yao, L., Nagai, Y., Miyata, K., Yoshizumi, M., Kagami, S., Kondo, S., Kiyomoto, H., Shokoji, T., Kimura, S., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000118519.66430.22 · Cited by 314
Kishi, T., Hirooka, Y., Kimura, Y., Ito, K., Shimokawa, H., & Takeshita, A. (2004) · Circulation · doi:10.1161/01.cir.0000128695.49900.12 · Cited by 306
Touyz, R. M., & Schiffrin, E. L. (2001) · Journal of Hypertension · doi:10.1097/00004872-200107000-00009 · Cited by 257
Self-citationRole of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice
Virdis, A., Neves, M. F., Amiri, F., Touyz, R. M., & Schiffrin, E. L. (2004) · Journal of Hypertension · doi:10.1097/00004872-200403000-00016 · Cited by 244
Self-citationPPARα Activator Effects on Ang II–Induced Vascular Oxidative Stress and Inflammation
Diep, Q. N., Amiri, F., Touyz, R. M., Cohn, J. S., Endemann, D., Neves, M. F., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/01.hyp.0000037969.41360.cc · Cited by 236
Self-citationRedox‐dependent signalling by angiotensin II and vascular remodelling in hypertension
Touyz, R. M., Tabet, F., & Schiffrin, E. L. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03930.x · Cited by 236
Self-citationAscorbic Acid Reduces Blood Pressure and Arterial Stiffness in Type 2 Diabetes
Mullan, B. A., Young, I. S., Fee, H., & McCance, D. R. (2002) · Hypertension · doi:10.1161/01.hyp.0000039961.13718.00 · Cited by 212
Antioxidants and Atherosclerosis: Don’t Throw Out the Baby With the Bath Water
Jialal, I., & Devaraj, S. (2003) · Circulation · doi:10.1161/01.cir.0000048966.26216.4c · Cited by 208
Yasunari, K., Maeda, K., Nakamura, M., & Yoshikawa, J. (2002) · Hypertension · doi:10.1161/hy0302.104670 · Cited by 200
Rodriguez-Iturbe, B., Zhan, C.-D., Quiroz, Y., Sindhu, R. K., & Vaziri, N. D. (2003) · Hypertension · doi:10.1161/01.hyp.0000052833.20759.64 · Cited by 191
Strategies to reduce oxidative stress in cardiovascular disease
HAMILTON, C. A., MILLER, W. H., AL-BENNA, S., Julia BROSNAN, M., DRUMMOND, R. D., McBRIDE, M. W., & DOMINICZAK, A. F. (2004) · Clinical Science · doi:10.1042/cs20030379 · Cited by 190
Park, J. B., Touyz, R. M., Chen, X., & Schiffrin, E. L. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02233-6 · Cited by 189
Self-citationPioglitazone Prevents Hypertension and Reduces Oxidative Stress in Diet-Induced Obesity
Dobrian, A. D., Schriver, S. D., Khraibi, A. A., & Prewitt, R. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000103629.01745.59 · Cited by 184
Enhanced Oxidative Stress and Impaired Thioredoxin Expression in Spontaneously Hypertensive Rats
Tanito, M., Nakamura, H., Kwon, Y.-W., Teratani, A., Masutani, H., Shioji, K., Kishimoto, C., Ohira, A., Horie, R., & Yodoi, J. (2004) · Antioxidants & Redox Signaling · doi:10.1089/152308604771978381 · Cited by 180
Reactive oxygen species in vascular biology: role in arterial hypertension
Touyz, R. M. (2003) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.1.1.91 · Cited by 171
Self-citationParavicini, T. M., Chrissobolis, S., Drummond, G. R., & Sobey, C. G. (2004) · Stroke · doi:10.1161/01.str.0000112974.37028.58 · Cited by 156
Wu, R., Lamontagne, D., & de Champlain, J. (2002) · Circulation · doi:10.1161/hc0302.102609 · Cited by 155
Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization
Morikawa, K., Shimokawa, H., Matoba, T., Kubota, H., Akaike, T., Talukder, M. A. H., Hatanaka, M., Fujiki, T., Maeda, H., Takahashi, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319351 · Cited by 153
Zheng, J.-S., Yang, X.-Q., Lookingland, K. J., Fink, G. D., Heßlinger, C., Kapatos, G., Kovesdi, I., & Chen, A. F. (2003) · Circulation · doi:10.1161/01.cir.0000089082.40285.c3 · Cited by 149
Renal Sympathetic Nerve Responses to Tempol in Spontaneously Hypertensive Rats
Shokoji, T., Nishiyama, A., Fujisawa, Y., Hitomi, H., Kiyomoto, H., Takahashi, N., Kimura, S., Kohno, M., & Abe, Y. (2003) · Hypertension · doi:10.1161/01.hyp.0000049621.85474.cf · Cited by 147
Tabet, F., Savoia, C., Schiffrin, E. L., & Touyz, R. M. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200408000-00009 · Cited by 144
Self-citationWard, N. C., Hodgson, J. M., Puddey, I. B., Mori, T. A., Beilin, L. J., & Croft, K. D. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.10.021 · Cited by 142
Wyche, K. E., Wang, S. S., Griendling, K. K., Dikalov, S., Austin, H. D., Rao, S., Fink, B., Harrison, D. G., & Zafari, A. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000126579.50711.62 · Cited by 134
Redox signaling in central neural regulation of cardiovascular function
Zimmerman, M. C., & Davisson, R. L. (2003) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2003.11.009 · Cited by 125
Yoshida, J., Yamamoto, K., Mano, T., Sakata, Y., Nishikawa, N., Nishio, M., Ohtani, T., Miwa, T., Hori, M., & Masuyama, T. (2004) · Hypertension · doi:10.1161/01.hyp.0000118017.02160.fa · Cited by 122
Serum Antioxidant Vitamins and Blood Pressure in the United States Population
Chen, J., He, J., Hamm, L. L., Batuman, V., & Whelton, P. K. (2002) · Hypertension · doi:10.1161/01.hyp.0000039962.68332.59 · Cited by 122
Redox regulation of the afferent arteriole and tubuloglomerular feedback
Wilcox, C. S. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.0001-6772.2003.01205.x · Cited by 104
Moreno, M. U., José, G. S., Orbe, J., Páramo, J. A., Beloqui, Ó., Dı́ez, J., & Zalba, G. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00331-4 · Cited by 102
Determinants of Platelet Activation in Human Essential Hypertension
Minuz, P., Patrignani, P., Gaino, S., Seta, F., Capone, M. L., Tacconelli, S., Degan, M., Faccini, G., Fornasiero, A., Talamini, G., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000105109.44620.1b · Cited by 99
Neutrophil activation and production of reactive oxygen species in pre-eclampsia
Lee, V. M., Quinn, P. A., Jennings, S. C., & Ng, L. L. (2003) · Journal of Hypertension · doi:10.1097/00004872-200302000-00032 · Cited by 92
Touyz, R. M., Campbell, N. R. C., Logan, A. G., Gledhill, N., Petrella, R. J., & Padwal, R. S. (2004) · PubMed · Cited by 89
Self-citationPerivascular Innervation of Penetrating Brain Parenchymal Arterioles
Cipolla, M. J., Li, R., & Vitullo, L. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200407000-00001 · Cited by 86
l -Arginine Reverses p47phox and gp91phox Expression Induced by High Salt in Dahl Rats
Fujii, S., Zhang, L., Igarashi, J., & Kosaka, H. (2003) · Hypertension · doi:10.1161/01.hyp.0000094557.36656.d0 · Cited by 81
Oxidative stress in malignant and non-malignant phase hypertension
Lip, G. Y. H., Edmunds, E., Nuttall, S., Landray, M., Blann, A. D., & Beevers, D. G. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001386 · Cited by 80
Recent trials of antioxidant therapy: what should we be telling our patients?
Hasnain, B. I., & Mooradian, A. D. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.4.327 · Cited by 69
Xanthine oxidase activity in the dexamethasone-induced hypertensive rat
Wallwork, C. J., Parks, D. A., & Schmid‐Schönbein, G. W. (2003) · Microvascular Research · doi:10.1016/s0026-2862(03)00019-0 · Cited by 63
Zalba, G., José, G. S., Beaumont, J., Fortuño, M. A., Fortuño, A., & Díez, J. (2001) · Circulation Research · doi:10.1161/01.res.88.2.217 · Cited by 62
Cited by
Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases
Phaniendra, A., Jestadi, D. B., & Periyasamy, L. (2015) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0446-0 · Cited by 2,886
Manna, P., & Jain, S. K. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0095 · Cited by 1,145
Oxidative stress in obesity: A critical component in human diseases
Marseglia, L., Manti, S., D’Angelo, G., Nicotera, A., Parisi, E., Di Rosa, G., Gitto, E., & Arrigo, T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010378 · Cited by 933
Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?
Senoner, T., & Dichtl, W. (2019) · Nutrients · doi:10.3390/nu11092090 · Cited by 868
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818
Metadata
- Authors
- Touyz, R. M.
- Venue
- Hypertension
- Published
- 2004-09
- Volume
- 44
- Issue
- 3
- Pages
- 248-252
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2099273954
- Cited by
- 866
- References
- 53
- FWCI
- 26.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.